Laxbene

Bisacodyl, the active ingredient in Laxbene, is a stimulant laxative presented as a rectal formulation for rectal use. It is used to treat constipation and to prepare the bowel before diagnostic procedures in adult patients.

GNH USA supplies Laxbene as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Laxbene, a stimulant laxative, acts on the lower gastrointestinal tract to promote bowel evacuation. - Constipation: provides relief by stimulating colonic peristalsis and increasing fluid secretion. - Bowel cleansing prior to diagnostic procedures: facilitates thorough emptying of the colon before colonoscopy or radiographic studies.

Adverse reactions may occur with rectal bisacodyl use.

Common Side Effects: - Abdominal cramps - Diarrhea - Rectal irritation or burning sensation - Nausea - Flatulence - Urgency to defecate

Serious or Rare Side Effects: - Severe electrolyte imbalance - Rectal ulceration or bleeding - Allergic reaction (rash, swelling, anaphylaxis) - Severe abdominal pain - Persistent rectal bleeding

Before using Laxbene, consider the following safety measures. - Contraindicated in acute abdominal pain or suspected bowel obstruction: avoid use. - Use with caution in patients with dehydration or electrolyte disorders: monitor status. - Pediatric use: limit to older children and follow prescriber guidance. - Elderly patients: start with the lowest effective dose and observe tolerance. - Pregnancy and lactation: safety not established; weigh benefits against potential risks. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Bisacodyl may interact with other agents that affect electrolyte balance or bowel motility.

Major Interactions (Avoid): - Concurrent use with other stimulant laxatives: risk of severe diarrhea and electrolyte loss. - Combination with high‑dose diuretics: may precipitate significant electrolyte disturbances. - Use with anticholinergic drugs that reduce gut motility: may diminish efficacy.

Moderate Interactions (Monitor Closely): - Digitalis glycosides: monitor serum potassium levels. - Corticosteroids: watch for increased risk of colonic perforation. - Magnesium‑containing antacids: may enhance laxative effect. - Opioid analgesics: may counteract bisacodyl’s action, requiring dose adjustment.